Global Amantadine HCl Oral Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Amantadine HCl Oral
- 1.1 Definition of Amantadine HCl Oral
- 1.2 Amantadine HCl Oral Segment by Type
- 1.2.1 Global Amantadine HCl Oral Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Tablet
- 1.2.3 Capsules
- 1.2.4 Syrup
- 1.3 Amantadine HCl Oral Segment by Applications
- 1.3.1 Global Amantadine HCl Oral Consumption Comparison by Applications (2014-2025)
- 1.3.2 Parkinson's disease
- 1.3.3 Influenza
- 1.4 Global Amantadine HCl Oral Overall Market
- 1.4.1 Global Amantadine HCl Oral Revenue (2014-2025)
- 1.4.2 Global Amantadine HCl Oral Production (2014-2025)
- 1.4.3 North America Amantadine HCl Oral Status and Prospect (2014-2025)
- 1.4.4 Europe Amantadine HCl Oral Status and Prospect (2014-2025)
- 1.4.5 China Amantadine HCl Oral Status and Prospect (2014-2025)
- 1.4.6 Japan Amantadine HCl Oral Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Amantadine HCl Oral Status and Prospect (2014-2025)
- 1.4.8 India Amantadine HCl Oral Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Amantadine HCl Oral
- 2.3 Manufacturing Process Analysis of Amantadine HCl Oral
- 2.4 Industry Chain Structure of Amantadine HCl Oral
3 Development and Manufacturing Plants Analysis of Amantadine HCl Oral
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Amantadine HCl Oral Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Amantadine HCl Oral
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Amantadine HCl Oral Production and Capacity Analysis
- 4.2 Amantadine HCl Oral Revenue Analysis
- 4.3 Amantadine HCl Oral Price Analysis
- 4.4 Market Concentration Degree
5 Amantadine HCl Oral Regional Market Analysis
- 5.1 Amantadine HCl Oral Production by Regions
- 5.1.1 Global Amantadine HCl Oral Production by Regions
- 5.1.2 Global Amantadine HCl Oral Revenue by Regions
- 5.2 Amantadine HCl Oral Consumption by Regions
- 5.3 North America Amantadine HCl Oral Market Analysis
- 5.3.1 North America Amantadine HCl Oral Production
- 5.3.2 North America Amantadine HCl Oral Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Amantadine HCl Oral Import and Export
- 5.4 Europe Amantadine HCl Oral Market Analysis
- 5.4.1 Europe Amantadine HCl Oral Production
- 5.4.2 Europe Amantadine HCl Oral Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Amantadine HCl Oral Import and Export
- 5.5 China Amantadine HCl Oral Market Analysis
- 5.5.1 China Amantadine HCl Oral Production
- 5.5.2 China Amantadine HCl Oral Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Amantadine HCl Oral Import and Export
- 5.6 Japan Amantadine HCl Oral Market Analysis
- 5.6.1 Japan Amantadine HCl Oral Production
- 5.6.2 Japan Amantadine HCl Oral Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Amantadine HCl Oral Import and Export
- 5.7 Southeast Asia Amantadine HCl Oral Market Analysis
- 5.7.1 Southeast Asia Amantadine HCl Oral Production
- 5.7.2 Southeast Asia Amantadine HCl Oral Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Amantadine HCl Oral Import and Export
- 5.8 India Amantadine HCl Oral Market Analysis
- 5.8.1 India Amantadine HCl Oral Production
- 5.8.2 India Amantadine HCl Oral Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Amantadine HCl Oral Import and Export
6 Amantadine HCl Oral Segment Market Analysis (by Type)
- 6.1 Global Amantadine HCl Oral Production by Type
- 6.2 Global Amantadine HCl Oral Revenue by Type
- 6.3 Amantadine HCl Oral Price by Type
7 Amantadine HCl Oral Segment Market Analysis (by Application)
- 7.1 Global Amantadine HCl Oral Consumption by Application
- 7.2 Global Amantadine HCl Oral Consumption Market Share by Application (2014-2019)
8 Amantadine HCl Oral Major Manufacturers Analysis
- 8.1 Zydus Pharmaceuticals
- 8.1.1 Zydus Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
- 8.1.2 Zydus Pharmaceuticals Product Introduction, Application and Specification
- 8.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Mylan
- 8.2.1 Mylan Amantadine HCl Oral Production Sites and Area Served
- 8.2.2 Mylan Product Introduction, Application and Specification
- 8.2.3 Mylan Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Teva
- 8.3.1 Teva Amantadine HCl Oral Production Sites and Area Served
- 8.3.2 Teva Product Introduction, Application and Specification
- 8.3.3 Teva Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Vertical Pharmaceuticals
- 8.4.1 Vertical Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
- 8.4.2 Vertical Pharmaceuticals Product Introduction, Application and Specification
- 8.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Adamas Pharmaceuticals
- 8.5.1 Adamas Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
- 8.5.2 Adamas Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Upsher-Smith
- 8.6.1 Upsher-Smith Amantadine HCl Oral Production Sites and Area Served
- 8.6.2 Upsher-Smith Product Introduction, Application and Specification
- 8.6.3 Upsher-Smith Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Sandoz
- 8.7.1 Sandoz Amantadine HCl Oral Production Sites and Area Served
- 8.7.2 Sandoz Product Introduction, Application and Specification
- 8.7.3 Sandoz Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Mikart Pharmaceuticals
- 8.8.1 Mikart Pharmaceuticals Amantadine HCl Oral Production Sites and Area Served
- 8.8.2 Mikart Pharmaceuticals Product Introduction, Application and Specification
- 8.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Pharmaceutical Associates, Inc. (PAI)
- 8.9.1 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Production Sites and Area Served
- 8.9.2 Pharmaceutical Associates, Inc. (PAI) Product Introduction, Application and Specification
- 8.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Wockhardt Bio AG
- 8.10.1 Wockhardt Bio AG Amantadine HCl Oral Production Sites and Area Served
- 8.10.2 Wockhardt Bio AG Product Introduction, Application and Specification
- 8.10.3 Wockhardt Bio AG Amantadine HCl Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 CMP Pharma
- 8.12 Bionpharma
- 8.13 Graviti Pharma
- 8.14 Alembic Pharmaceuticals
- 8.15 Strides Pharma
- 8.16 Heritage Pharmaceuticals
9 Development Trend of Analysis of Amantadine HCl Oral Market
- 9.1 Global Amantadine HCl Oral Market Trend Analysis
- 9.1.1 Global Amantadine HCl Oral Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Amantadine HCl Oral Regional Market Trend
- 9.2.1 North America Amantadine HCl Oral Forecast 2019-2025
- 9.2.2 Europe Amantadine HCl Oral Forecast 2019-2025
- 9.2.3 China Amantadine HCl Oral Forecast 2019-2025
- 9.2.4 Japan Amantadine HCl Oral Forecast 2019-2025
- 9.2.5 Southeast Asia Amantadine HCl Oral Forecast 2019-2025
- 9.2.6 India Amantadine HCl Oral Forecast 2019-2025
- 9.3 Amantadine HCl Oral Market Trend (Product Type)
- 9.4 Amantadine HCl Oral Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Amantadine HCl Oral Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.
The global Amantadine HCl Oral market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Amantadine HCl Oral volume and value at global level, regional level and company level. From a global perspective, this report represents overall Amantadine HCl Oral market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Amantadine HCl Oral in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Amantadine HCl Oral manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Zydus Pharmaceuticals
Mylan
Teva
Vertical Pharmaceuticals
Adamas Pharmaceuticals
Upsher-Smith
Sandoz
Mikart Pharmaceuticals
Pharmaceutical Associates, Inc. (PAI)
Wockhardt Bio AG
CMP Pharma
Bionpharma
Graviti Pharma
Alembic Pharmaceuticals
Strides Pharma
Heritage Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablet
Capsules
Syrup
Segment by Application
Parkinson's disease
Influenza